Skip to main content
PMC home page
Cellular & Molecular Biology Letters logoLink to Cellular & Molecular Biology Letters
. 2012 Nov 16;18(1):58–74. doi: 10.2478/s11658-012-0039-y

Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y CELLS

Patchara Ngok-Ngam 1, Piyajit Watcharasit 1,2,✉, Apinya Thiantanawat 1,2, Jutamaad Satayavivad 1,2
PMCID: PMC6275584  PMID: 23161404

Abstract

Glycogen synthase kinase-3 (GSK3) and p53 play crucial roles in the mitochondrial apoptotic pathway and are known to interact in the nucleus. However, it is not known if GSK3 has a regulatory role in the mitochondrial translocation of p53 that participates in apoptotic signaling following DNA damage. In this study, we demonstrated that lithium and SB216763, which are pharmacological inhibitors of GSK3, attenuated p53 accumulation and caspase-3 activation, as shown by PARP cleavage induced by the DNA-damaging agents doxorubicin, etoposide and camptothecin. Furthermore, each of these agents induced translocation of p53 to the mitochondria and activated the mitochondrial pathway of apoptosis, as evidenced by the release of cytochrome C from the mitochondria. Both mitochondrial translocation of p53 and mitochondrial release of cytochrome C were attenuated by inhibition of GSK3, indicating that GSK3 promotes the DNA damage-induced mitochondrial translocation of p53 and the mitochondrial apoptosis pathway. Interestingly, the regulation of p53 mitochondrial translocation by GSK3 was only evident with wild-type p53, not with mutated p53. GSK3 inhibition also reduced the phosphorylation of wild-type p53 at serine 33, which is induced by doxorubicin, etoposide and camptothecin in the mitochondria. Moreover, inhibition of GSK3 reduced etoposide-induced association of p53 with Bcl2 and Bax oligomerization. These findings show that GSK3 promotes the mitochondrial translocation of p53, enabling its interaction with Bcl2 to allow Bax oligomerization and the subsequent release of cytochrome C. This leads to caspase activation in the mitochondrial pathway of intrinsic apoptotic signaling.

Key words: GSK3, p53, Mitochondrial translocation, Apoptosis, Bax oligomerization, Cytochrome C, Phosphorylation, Etoposide, Doxorubicin, Camptothecin

Full Text

The Full Text of this article is available as a PDF (649.0 KB).

Abbreviations used

ATCC

American Type Culture Collection

EDTA

ethylenediaminetetraacetic acid

EGTA

ethyleneglycoltetraacetic acid

FBS

fetal bovine serum

GSK3

glycogen synthase kinase 3

HEPES

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid

IP

immunoprecipitation

MEM

minimum essential medium

PARP

poly ADP ribose polymerase

PMSF

phenylmethylsulfonylfluoride

PUMA

the p53 upregulated modulator of apoptosis

SDS

sodium dodecyl sulfate

References

  • 1.Beurel E., Jope R.S. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 2006;79:173–189. doi: 10.1016/j.pneurobio.2006.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kaidanovich-Beilin O., Woodgett J.R. GSK-3: functional insights from cell biology and animal models. Front Mol. Neurosci. 2011;4:40. doi: 10.3389/fnmol.2011.00040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gomez-Sintes R., Hernandez F., Lucas J.J., Avila J. GSK-3 mouse models to study neuronal apoptosis and neurodegeneration. Front. Mol. Neurosci. 2011;4:45. doi: 10.3389/fnmol.2011.00045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Watcharasit P., Bijur G.N., Zmijewski J.W., Song L., Zmijewska A., Chen X., Johnson G.V., Jope R.S. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc. Natl. Acad. Sci. USA. 2002;99:7951–7955. doi: 10.1073/pnas.122062299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Qu L., Huang S., Baltzis D., Rivas-Estilla A.M., Pluquet O., Hatzoglou M., Koumenis C., Taya Y., Yoshimura A., Koromilas A.E. Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev. 2004;18:261–277. doi: 10.1101/gad.1165804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Song L., De Sarno P., Jope R.S. Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J. Biol. Chem. 2002;277:44701–44708. doi: 10.1074/jbc.M206047200. [DOI] [PubMed] [Google Scholar]
  • 7.Kim A.J., Shi Y., Austin R.C., Werstuck G.H. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J. Cell Sci. 2005;118:89–99. doi: 10.1242/jcs.01562. [DOI] [PubMed] [Google Scholar]
  • 8.King T.D., Bijur G.N., Jope R.S. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res. 2001;919:106–114. doi: 10.1016/S0006-8993(01)03005-0. [DOI] [PubMed] [Google Scholar]
  • 9.King T.D., Jope R.S. Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress. Neuroreport. 2005;16:597–601. doi: 10.1097/00001756-200504250-00016. [DOI] [PubMed] [Google Scholar]
  • 10.Pap M., Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem. 1998;273:19929–19932. doi: 10.1074/jbc.273.32.19929. [DOI] [PubMed] [Google Scholar]
  • 11.Watcharasit P., Bijur G.N., Song L., Zhu J., Chen X., Jope R.S. Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J. Biol. Chem. 2003;278:48872–48879. doi: 10.1074/jbc.M305870200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Turenne G.A., Price B.D. Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53’s transcriptional activity. BMC Cell Biol. 2001;2:12. doi: 10.1186/1471-2121-2-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855–4878. [PubMed] [Google Scholar]
  • 14.Harms K., Nozell S., Chen X. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 2004;61:822–842. doi: 10.1007/s00018-003-3304-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dumont P., Leu J.I., Della Pietra A.C., III, George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003;33:357–365. doi: 10.1038/ng1093. [DOI] [PubMed] [Google Scholar]
  • 16.Marchenko N., Zaika A., Moll U. Death signal-induced localization of p53 protein to mitochondria A potential role in apoptotic signaling. J. Biol. Chem. 2000;275:16202–16212. doi: 10.1074/jbc.275.21.16202. [DOI] [PubMed] [Google Scholar]
  • 17.Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell. 2003;11:577–590. doi: 10.1016/S1097-2765(03)00050-9. [DOI] [PubMed] [Google Scholar]
  • 18.Moll U.M., Wolff S., Speidel D., Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 2005;17:631–636. doi: 10.1016/j.ceb.2005.09.007. [DOI] [PubMed] [Google Scholar]
  • 19.Murphy M.E., Leu J.I., George D.L. p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle. 2004;3:836–839. doi: 10.4161/cc.3.7.956. [DOI] [PubMed] [Google Scholar]
  • 20.Watcharasit P., Thiantanawat A., Satayavivad J. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J. Appl. Toxicol. 2008;28:466–474. doi: 10.1002/jat.1296. [DOI] [PubMed] [Google Scholar]
  • 21.Chabner B.A., Amrein P.C., Druker B.J., Michaelson M.D., Mitsiades C.S., Goss P.E., Ryan D.P., Ramachandra S., Richardson P.G., Supko J.G., Wilson W.H. Antineoplastic Agents. In: Brunton L.L., editor. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th Edition. New York: The McGraw-Hill Co. Inc.; 2005. pp. 1315–1403. [Google Scholar]
  • 22.Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. USA. 1999;96:8745–8750. doi: 10.1073/pnas.96.15.8745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.De Sarno P., Li X., Jope R.S. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology. 2002;43:1158–1164. doi: 10.1016/S0028-3908(02)00215-0. [DOI] [PubMed] [Google Scholar]
  • 24.Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Roxbee Cox L., Mills D., Brown M.J., Haigh D., Ward R.W., Smith D.G., Murray K.J., Reith A.D., Holder J.C. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 2000;7:793–803. doi: 10.1016/S1074-5521(00)00025-9. [DOI] [PubMed] [Google Scholar]
  • 25.Erster S., Mihara M., Kim R., Petrenko O., Moll U. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol. 2004;24:6728–6741. doi: 10.1128/MCB.24.15.6728-6741.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chen X., Ko L.J., Jayaraman L., Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 1996;10:2438–2451. doi: 10.1101/gad.10.19.2438. [DOI] [PubMed] [Google Scholar]
  • 27.Haupt Y., Rowan S., Shaulian E., Vousden K.H., Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 1995;9:2170–2183. doi: 10.1101/gad.9.17.2170. [DOI] [PubMed] [Google Scholar]
  • 28.Ahn B.Y., Trinh D.L., Zajchowski L.D., Lee B., Elwi A.N., Kim S.W. Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer. Oncogene. 2010;29:1155–1166. doi: 10.1038/onc.2009.413. [DOI] [PubMed] [Google Scholar]
  • 29.O’Connor P.M., Jackman J., Bae I., Myers T.G., Fan S., Mutoh M., Scudiero D.A., Monks A., Sausville E.A., Weinstein J.N., Friend S., Fornace A.J., Jr., Kohn K. W. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 1997;57:4285–4300. [PubMed] [Google Scholar]
  • 30.Olsson A., Manzl C., Strasser A., Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ. 2007;14:1561–1575. doi: 10.1038/sj.cdd.4402196. [DOI] [PubMed] [Google Scholar]
  • 31.Vaseva A.V., Moll U.M. The mitochondrial p53 pathway. Biochim. Biophys. Acta. 2009;1787:414–420. doi: 10.1016/j.bbabio.2008.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chipuk J., Kuwana T., Bouchier-Hayes L., Droin N., Newmeyer D., Schuler M., Green D. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010–1014. doi: 10.1126/science.1092734. [DOI] [PubMed] [Google Scholar]
  • 33.Marchenko N.D., Wolff S., Erster S., Becker K., Moll U.M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 2007;26:923–934. doi: 10.1038/sj.emboj.7601560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.David R. Apoptosis: A lipid trigger of MOMP. Nat. Rev. Mol. Cell Biol. 2012;13:208–209. doi: 10.1038/nrm3320. [DOI] [PubMed] [Google Scholar]
  • 35.Moll U., Marchenko N., Zhang X. p53 and Nur77/TR3-transcription factors that directly target mitochondria for cell death induction. Oncogene. 2006;25:4725–4743. doi: 10.1038/sj.onc.1209601. [DOI] [PubMed] [Google Scholar]
  • 36.Linseman D.A., Butts B.D., Precht T.A., Phelps R.A., Le S.S., Laessig T.A., Bouchard R.J., Florez-McClure M.L., Heidenreich K.A. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J. Neurosci. 2004;24:9993–10002. doi: 10.1523/JNEUROSCI.2057-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tan J., Zhuang L., Leong H.S., Iyer N.G., Liu E.T., Yu Q. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res. 2005;65:9012–9020. doi: 10.1158/0008-5472.CAN-05-1226. [DOI] [PubMed] [Google Scholar]
  • 38.Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–1851. [PubMed] [Google Scholar]
  • 39.Nemajerova A., Erster S., Moll U.M. The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ. 2005;12:197–200. doi: 10.1038/sj.cdd.4401526. [DOI] [PubMed] [Google Scholar]
  • 40.Guan L., Huang F., Li Z., Han B., Jiang Q., Ren Y., Yang Y., Xu C. P53 transcription-independent activity mediates selenite-induced acute promyelocytic leukemia NB4 cell apoptosis. BMB Rep. 2008;41:745–750. doi: 10.5483/BMBRep.2008.41.10.745. [DOI] [PubMed] [Google Scholar]
  • 41.Park B.S., Song Y.S., Yee S.B., Lee B.G., Seo S.Y., Park Y.C., Kim J.M., Kim H. M., Yoo Y.H. Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis. 2005;10:193–200. doi: 10.1007/s10495-005-6074-7. [DOI] [PubMed] [Google Scholar]
  • 42.Bijur G.N., Jope R.S. Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport. 2003;14:2415–2419. doi: 10.1097/00001756-200312190-00025. [DOI] [PubMed] [Google Scholar]
  • 43.Talos F., Petrenko O., Mena P., Moll U.M. Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res. 2005;65:9971–9981. doi: 10.1158/0008-5472.CAN-05-1084. [DOI] [PubMed] [Google Scholar]

Articles from Cellular & Molecular Biology Letters are provided here courtesy of BMC

RESOURCES